![]() |
市場調查報告書
商品編碼
2096590
動物咀嚼片市場:全球市場預測(2026-2032 年)Animal Chewables Market - Global Forecast 2026-2032 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計到 2032 年,動物咀嚼片市場將成長至 2.7255 億美元,複合年成長率為 7.64%。
| 主要市場統計數據 | |
|---|---|
| 基準年(2025 年) | 1.6271億美元 |
| 預計年份(2026年) | 1.8069億美元 |
| 預測年份(2032年) | 2.7255億美元 |
| 複合年成長率() | 7.64% |
隨著寵物飼主尋求兼具偏好、功能性和易用性的便利產品,動物咀嚼片正成為寵物健康、動物營養、獸醫學和伴侶動物保健領域的重要策略類別。咀嚼片用途廣泛,涵蓋牙齒護理、消化系統健康、關節活動、鎮靜、皮膚和毛髮護理、寄生蟲控制以及營養補充等。推動市場需求的因素包括寵物「擬人化」、預防醫學的普及、獸醫推薦的健康實踐的推廣,以及消費者日益偏好能夠減輕動物和飼主用藥壓力的產品。此外,消費者對原料透明度、潔淨標示、物種特異性配方以及對安全性、有效性和監管合規性日益嚴格的要求,也影響著這一品類的發展。對於製造商、經銷商、獸醫和零售商而言,動物咀嚼片市場正在從單純的零食劑型轉變為以科學為基礎、針對特定健康且適應生命週期的解決方案,這些解決方案與可衡量的健康益處和負責任的寵物護理相一致。
動物咀嚼片市場正經歷一場變革,寵物健康、獸醫治療和功能性營養的融合是推動這項變革的主要動力。消費者越來越期望咀嚼片在保持美味、口感和易消化性的同時,還能發揮特定的功效,這迫使配方研發人員在活性成分的穩定性和感官特性之間尋求平衡。儘管獸醫管道仍然對產品的可信度有著重要影響,尤其是針對特定健康狀況的藥用咀嚼片和補充劑,但電子商務和訂閱式補貨模式正在促進產品的供應和持續使用。同時,監管機構和相關人員也越來越重視標籤的準確性、劑量的一致性、不利事件監測以及支持健康聲明的證據。原料的創新正在各個領域加速發展,包括益生菌、ω脂肪酸、膠原膠原蛋白、葡萄糖胺、軟骨素、植物來源成分、在允許的範圍內使用大麻來源成分以及新型蛋白質,每一種都需要仔細評估其安全性、生物利用度和物種特異性耐受性。此外,永續性重要,重點在於負責任地採購動物性成分、使用可回收包裝以及減少生產過程中的廢棄物。這些變化正促使產業朝著以臨床為依據的配方、透明的供應鏈以及產品定位與動物健康證據之間更緊密的聯繫方向發展。
人工智慧 (AI) 透過配方最佳化、品質保證、個人化消費者體驗和獸醫決策支持,對動物咀嚼片行業的影響日益顯著。 AI 驅動的分析能夠識別成分性能、偏好測試、不利事件報告和客戶反饋中的模式,使製造商能夠更有效地改進咀嚼片的質地、風味系統和活性成分輸送特性。在生產製造方面,機器視覺和預測性維護可確保形狀、重量、包覆、水分管理和缺陷檢測的一致性——這對劑量可靠性和儲存穩定性至關重要。 AI 驅動的需求預測可改善獸醫診所、專賣店和線上管道的庫存規劃,無需依賴基於猜測的擴大策略。在數位健康生態系統中,AI 可以將寵物檔案、品種特有的體質傾向、年齡、體重、飲食和健康目標關聯起來,從而推薦合適的咀嚼片類別。然而,這些工具必須在獸醫監督、資料隱私管理以及對健康益處聲明的明確限制下運作。因此,人工智慧的累積影響遠遠超出了簡單的自動化。這包括建構一條個人化動物咀嚼片的價值鏈,該價值鏈能夠實現更快的反應速度,並以實證為基礎。如果負責任地實施,它可以提高合規性,確保產品品質穩定,並增強消費者信心。
亞太地區的特點是伴侶動物數量快速成長、都市區寵物飼養量增加以及消費者對高階寵物保健日益成長的興趣。其中,中國、印度、日本、韓國和澳洲在零售市場成熟度、獸醫服務可近性和功能性營養意識方面呈現不同的發展趨勢。北美地區憑藉其完善的獸醫診療流程、寵物「人性化」程度的提高、電子商務的普及以及對用於牙齒、關節、鎮靜和預防保健的咀嚼片的需求,仍然保持著重要的市場地位。隨著都市區寵物飼養量的增加,以及消費者對價格適中且功能性強的產品需求日益成長,拉丁美洲的重要性也日益凸顯,其中巴西和墨西哥在這一領域的發展中扮演著核心角色。在歐洲,消費者對透明的標籤、高產品安全標準和規範的健康功效聲明有著強烈的需求,合規性、可追溯性和永續的原料採購是關鍵的差異化因素。在中東,市場特點是都市區高階寵物護理服務的日益普及、獸醫基礎設施的改善以及進口和專業寵物保健產品的可及性提高。在非洲,隨著人們對伴侶動物健康的認知不斷提高,以及正規寵物護理零售和獸醫服務的普及,新的機會正在湧現。然而,可及性、價格和分銷仍然是關鍵考慮因素。在所有地區,動物咀嚼片都受益於預防性健康管理理念的轉變,但要取得成功,需要根據當地獸醫實踐、法律規範和消費者期望,調整配方、定價、功效聲明和銷售管道策略。
在東協市場,都市化、可支配收入的成長以及現代寵物零售業的蓬勃發展,正推動著人們對伴侶動物健康的日益關注,進一步提升了咀嚼型寵物產品的重要性。然而,各地不同的監管環境和分銷管道,使得企業必須制定本地化的打入市場策略。在海灣合作理事會(GCC)地區,人們對高階寵物產品的興趣日益濃厚,尤其是在能夠便捷地前往獸醫診所和專賣店的都市區中。進口產品往往憑藉其在品質、偏好和品牌信譽方面的良好口碑競爭。在歐盟,產品安全、嚴格的標籤規定、原料可追溯性和功效聲明至關重要,因此,對於咀嚼型營養補充劑、零食和藥品而言,合規性必不可少。金磚國家擁有多元化且規模龐大的需求基礎,這主要得益於其大規模的伴侶動物數量、不斷壯大的寵物主人中產階級以及日益成長的電子商務,但本地化生產、價格可承受性和合規性仍然至關重要。在七國集團(G7)國家,寵物照護行為普遍成熟,對臨床證據的期望較高,零售業發展成熟,且對特定疾病的咀嚼片的需求日益成長,這些咀嚼片旨在支持老年寵物的健康、口腔衛生、運動功能、消化功能和壓力管理。北約成員國與多個寵物照護市場高度重疊,這些市場中供應鏈的韌性、品質保證和合規的跨境貿易慣例支撐著該品類的穩定性。在這些國家,產業相關人員需要認知到,動物咀嚼片並非一個全球統一的類別。購買行為受到收入水準、獸醫參與度、對寵物的文化態度、進口法規以及專賣店和線上零售通路成熟度的影響。
美國是寵物咀嚼片的主要市場,這得益於其對寵物的「人性化」認知、與獸醫的密切聯繫、活躍的線上購物以及消費者對牙齒護理、運動功能、放鬆、消化和預防保健等功能性產品的濃厚興趣。加拿大也呈現類似的偏好,日益關注產品安全、成分透明度以及可靠的零售和獸醫通路。在墨西哥,隨著都市化的推進和功能性零食及營養補充劑供應的改善,寵物護理意識正在不斷提高,但價格和分銷網路仍然是關鍵挑戰。巴西是拉丁美洲寵物文化最活躍的國家之一,人們對高階營養和健康導向產品的興趣日益濃厚。英國、德國、法國、義大利和西班牙是重要的歐洲市場,產品品質、正確的標籤、永續性和基於證據的功效聲明會影響產品的分銷,寵物飼主也越來越傾向於選擇咀嚼片來維護老年寵物的健康和日常保健。在俄羅斯,對寵物營養和護理產品的需求仍然強勁,但供應鏈狀況、進口供應和監管因素可能會影響產品的供應。在中國,隨著寵物飼養在都市區的普及以及消費者轉向電子商務、高階營養食品和功能性保健產品,寵物咀嚼片市場正迅速發展。印度雖然仍處於發展初期,但也受益於寵物飼養量的成長、獸醫保健意識的提高以及數位零售通路的拓展。在日本和韓國,寵物照護行為日益成熟,人們對小型犬和老年寵物的解決方案表現出濃厚的興趣,並且對偏好、方便易用且具有針對性的產品配方有著顯著的需求。在澳大利亞,對動物健康、安全和負責任的寵物護理的高標準推動了人們對預防性和針對特定症狀的咀嚼片產品的興趣。總而言之,這些國家特有的趨勢表明,動物咀嚼片的成長與寵物數量動態、對獸醫的信任、監管合規性、產品偏好以及根據當地動物健康需求定製配方的能力密切相關。
產業領導者應優先考慮實證配方、物種適宜的劑量設計和透明的標籤,以增強獸醫和消費者管道的信任。產品開發團隊應投資於偏好科學、活性成分穩定性以及生物利用度測試,以確保咀嚼片在不影響口感或安全性的前提下,提供一致的療效。監管團隊應在目標市場中嚴格監管健康標籤、成分核准、標籤要求以及不利事件監測。銷售負責人應制定針對不同管道的策略,區分獸醫推薦產品、專業零售產品和數位訂閱模式,同時確保針對寵物飼主進行持續的宣傳活動。供應鏈團隊應透過多元化合格原料來源、加強品管以及評估永續包裝方案,滿足韌性和環境方面的要求。企業也應負責任地利用數位工具和人工智慧來支援個人化、需求預測和產品改進,同時保護消費者資料並避免發布未經證實的醫療聲明。最後,在這個安全、合規和可衡量的動物健康結果越來越重要的類別中,與獸醫、營養師和品質認證製造商夥伴關係將有助於加快信譽的提升。
對動物咀嚼片類別進行穩健的分析需要結合二手資料研究、專家檢驗、法規審查和結構化資料檢驗。二手資料研究包括分析獸醫健康指南、寵物營養標準、監管出版刊物、科學文獻、行業數據、零售通路觀察、專利趨勢以及公開的原料安全性和產品功效資訊。專家驗證研究應涵蓋獸醫、動物營養學家、製造商、經銷商、零售商、監管專家和寵物護理專業人員,以檢驗需求促進因素、配方挑戰、分銷管道趨勢和區域差異。資料檢驗應整合科學證據、監管要求、消費行為和供應鏈實際情況,避免過度依賴單一資訊來源。本報告應明確排除未經證實的預測,而應重點關注檢驗的趨勢、擴散指標、合規因素、產品創新模式和戰略意義。品管必須確保所獲得的見解準確、客觀且與動物咀嚼片相關的決策有關,包括檢驗資訊來源、確保一致性、規範術語以及審查標籤的依據。
動物咀嚼片正逐漸演變為寵物健康、獸醫學、功能營養和便捷給藥方式等多個領域的複雜交匯點。這一品類的發展受到以下因素的影響:人們預防保健意識的提高、對偏好和成分透明度的更高期望,以及對牙科、消化、運動、鎮靜、皮膚毛髮和整體健康等領域循證療效的日益成長的需求。儘管不同地區和國家的具體情況差異很大,但通用的成功因素包括:符合監管要求、獲得獸醫信任、產品安全、劑量一致性以及與當地寵物護理實踐的契合。人工智慧、數位商務和先進的生產控制技術正在開闢新的可能性,但負責任的實施仍然至關重要。透過結合科學信譽、消費者教育、在地化策略和強大的供應鏈,產業相關人員可以在動物咀嚼片市場建立競爭優勢,同時提供更安全、更有效、更可靠的動物健康解決方案。
The Animal Chewables Market is projected to grow by USD 272.55 million at a CAGR of 7.64% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 162.71 million |
| Estimated Year [2026] | USD 180.69 million |
| Forecast Year [2032] | USD 272.55 million |
| CAGR (%) | 7.64% |
Animal chewables are becoming a strategic category across pet health, animal nutrition, veterinary care, and companion animal wellness as owners seek convenient formats that combine palatability, functional benefits, and ease of administration. Chewable products support use cases ranging from dental care and digestive health to joint mobility, calming, skin and coat support, parasite control, and nutraceutical supplementation. Demand is being shaped by pet humanization, increased preventive care, broader adoption of veterinary-recommended wellness routines, and rising consumer preference for formats that reduce dosing stress for animals and caregivers. The category is also influenced by ingredient transparency, clean-label expectations, species-specific formulation, and heightened scrutiny around safety, efficacy, and regulatory compliance. For manufacturers, distributors, veterinarians, and retailers, the animal chewables landscape is shifting from simple treat-based delivery toward science-led, condition-specific, and lifecycle-oriented solutions that align with measurable health outcomes and responsible pet ownership.
The animal chewables landscape is undergoing a transformation driven by the convergence of pet wellness, veterinary therapeutics, and functional nutrition. Consumers increasingly expect chewables to deliver targeted benefits while maintaining appealing taste, texture, and digestibility, pushing formulators to balance active ingredient stability with sensory performance. Veterinary channels continue to influence product credibility, particularly for medicated chewables and condition-specific supplements, while e-commerce and subscription-based replenishment models are improving access and continuity of use. At the same time, regulators and industry stakeholders are placing greater emphasis on accurate labeling, dosage consistency, adverse event monitoring, and substantiation of health claims. Ingredient innovation is accelerating across probiotics, omega fatty acids, collagen, glucosamine, chondroitin, botanicals, hemp-derived ingredients where permitted, and novel proteins, though each requires careful evaluation for safety, bioavailability, and species-specific tolerance. Sustainability is also becoming more relevant, with attention on responsibly sourced animal ingredients, recyclable packaging, and reduced waste in manufacturing. These shifts are encouraging the industry to move toward clinically informed formulation, transparent supply chains, and stronger alignment between product positioning and animal health evidence.
Artificial intelligence is increasingly influencing animal chewables through formulation optimization, quality assurance, consumer personalization, and veterinary decision support. AI-enabled analytics can help identify patterns in ingredient performance, palatability testing, adverse event reports, and customer feedback, allowing producers to refine chew texture, flavor systems, and active delivery profiles more efficiently. In manufacturing environments, machine vision and predictive maintenance can support consistent shape, weight, coating, moisture control, and defect detection, which is important for dosage reliability and shelf stability. AI-driven demand sensing can improve inventory planning across veterinary clinics, specialty stores, and online channels without relying on speculative expansion strategies. In digital health ecosystems, AI can connect pet profiles, breed predispositions, age, weight, diet, and wellness goals to recommend appropriate chewable categories, although such tools must be governed by veterinary oversight, data privacy controls, and clear limits on health claims. The cumulative impact of artificial intelligence is therefore not simply automation; it is the creation of a more responsive, evidence-oriented, and personalized animal chewables value chain that can enhance compliance, product consistency, and consumer trust when responsibly implemented.
Asia-Pacific is characterized by rapid companion animal adoption, urban pet ownership, and growing interest in premium pet wellness, with China, India, Japan, South Korea, and Australia showing distinct patterns in retail maturity, veterinary access, and functional nutrition awareness. North America remains highly influential due to established veterinary care routines, strong pet humanization, broad e-commerce penetration, and demand for dental, joint, calming, and preventive health chewables. Latin America is gaining relevance as pet ownership expands across urban households and consumers increasingly seek affordable yet functional formats, with Brazil and Mexico playing central roles in category development. Europe demonstrates strong demand for transparent labeling, high product safety standards, and regulated health claims, making compliance, traceability, and sustainable ingredient sourcing important differentiators. The Middle East is shaped by rising premium pet care adoption in urban centers, growing veterinary infrastructure, and increasing availability of imported and specialized animal wellness products. Africa presents an emerging opportunity profile supported by gradual growth in formal pet care retail, veterinary services, and awareness of companion animal health, though accessibility, affordability, and distribution remain important considerations. Across all regions, animal chewables are benefiting from the broader shift toward preventive wellness, but success depends on adapting formulation, pricing, claims, and channel strategies to local veterinary practices, regulatory frameworks, and consumer expectations.
ASEAN markets are becoming increasingly relevant for animal chewables as urbanization, rising disposable incomes, and growth in modern pet retail support higher awareness of companion animal wellness, while diverse regulatory and distribution environments require localized entry strategies. The GCC is seeing stronger interest in premium pet products, particularly in urban households with access to veterinary clinics and specialty retail, with imported products often competing on quality perception, palatability, and brand trust. The European Union places significant emphasis on product safety, labeling discipline, ingredient traceability, and claims substantiation, making regulatory readiness essential for chewable supplements, treats, and medicated formats. BRICS economies offer a varied but important demand base, combining large companion animal populations, expanding middle-class pet ownership, and increasing digital commerce, while local manufacturing, affordability, and regulatory navigation remain critical. G7 countries generally reflect mature pet care behaviors, high expectations for clinical evidence, strong retail sophistication, and growing demand for condition-specific chewables that support aging pets, dental health, mobility, digestion, and stress management. NATO member countries overlap with several advanced pet care markets where supply chain resilience, quality assurance, and compliant cross-border trade practices support category stability. Across these groups, industry participants must recognize that animal chewables are not a uniform global category; purchasing behavior is shaped by income levels, veterinary involvement, cultural attitudes toward pets, import rules, and the maturity of specialty and online retail channels.
The United States is a leading demand environment for animal chewables due to widespread pet humanization, strong veterinary engagement, high online purchasing activity, and consumer interest in functional products for dental care, mobility, calming, digestion, and preventive wellness. Canada reflects similar preferences with heightened attention to product safety, ingredient transparency, and trusted retail and veterinary channels. Mexico is seeing expanding pet care awareness supported by urbanization and growing availability of functional treats and supplements, while affordability and distribution remain central. Brazil has one of the most dynamic companion animal cultures in Latin America, with rising interest in premium nutrition and wellness-oriented formats. The United Kingdom, Germany, France, Italy, and Spain represent important European markets where product quality, labeling compliance, sustainability, and evidence-backed claims influence adoption, while pet owners increasingly seek chewables that support aging animals and everyday wellness. Russia maintains demand for pet nutrition and care products, though supply chain conditions, import availability, and regulatory factors can affect product access. China is advancing rapidly as pet ownership expands in cities and consumers turn to e-commerce, premium nutrition, and functional wellness products. India is developing from a lower base but benefits from growing companion animal ownership, veterinary awareness, and digital retail access. Japan and South Korea show sophisticated pet care behaviors, strong interest in small-breed and aging-pet solutions, and demand for palatable, convenient, and specialized formulations. Australia emphasizes high standards for animal health, safety, and responsible pet care, supporting interest in preventive and condition-specific chewables. Together, these country-level dynamics show that growth in animal chewables is tied to pet demographics, veterinary trust, regulatory compliance, product palatability, and the ability to tailor formulations to local animal health priorities.
Industry leaders should prioritize evidence-backed formulation, species-appropriate dosage design, and transparent labeling to strengthen trust across veterinary and consumer channels. Product development teams should invest in palatability science, active ingredient stability, and bioavailability testing to ensure that chewables deliver consistent performance without compromising taste or safety. Regulatory teams should maintain strong oversight of health claims, ingredient permissibility, labeling requirements, and adverse event monitoring across target markets. Commercial leaders should build channel-specific strategies that differentiate veterinary-recommended products, specialty retail offerings, and digital subscription formats while ensuring consistent education for pet owners. Supply chain teams should diversify qualified ingredient sources, reinforce quality controls, and evaluate sustainable packaging options to address resilience and environmental expectations. Companies should also use digital tools and AI responsibly to support personalization, demand planning, and product improvement while protecting consumer data and avoiding unsupported medical claims. Finally, partnerships with veterinarians, nutrition experts, and quality-certified manufacturers can help accelerate credibility in a category where safety, compliance, and measurable animal wellness outcomes are increasingly important.
A robust research methodology for the animal chewables category should combine secondary research, primary expert validation, regulatory review, and structured data triangulation. Secondary research includes analysis of veterinary health guidelines, pet nutrition standards, regulatory publications, scientific literature, trade data, retail channel observations, patent activity, and publicly available information on ingredient safety and product claims. Primary research should engage veterinarians, animal nutritionists, manufacturers, distributors, retailers, regulatory specialists, and pet care professionals to validate demand drivers, formulation challenges, channel dynamics, and regional differences. Data triangulation should reconcile insights across scientific evidence, regulatory requirements, consumer behavior, and supply chain realities to avoid overreliance on any single source. The methodology should explicitly exclude unsupported projections and instead focus on verified trends, adoption indicators, compliance factors, product innovation patterns, and strategic implications. Quality control should include source verification, consistency checks, terminology standardization, and review of claim substantiation to ensure that insights remain accurate, objective, and relevant for decision-making in animal chewables.
Animal chewables are evolving into a sophisticated intersection of pet wellness, veterinary care, functional nutrition, and convenient product delivery. The category is being shaped by rising preventive health awareness, increased expectations for palatability and ingredient transparency, and stronger demand for evidence-backed benefits across dental, digestive, mobility, calming, skin and coat, and general wellness applications. Regional and country dynamics vary widely, but common success factors include regulatory compliance, veterinarian trust, product safety, dosage consistency, and alignment with local pet ownership behaviors. Artificial intelligence, digital commerce, and advanced manufacturing controls are adding new capabilities, but responsible implementation remains essential. Industry participants that combine scientific credibility, consumer education, localized strategies, and resilient supply chains will be better positioned to compete in the animal chewables landscape while supporting safer, more effective, and more trusted animal health solutions.